Adherence of randomised controlled trials using artificial intelligence in ophthalmology to CONSORT-AI guidelines: a systematic review and critical appraisal

Purpose Many efforts have been made to explore the potential of deep learning and artificial intelligence (AI) in disciplines such as medicine, including ophthalmology. This systematic review aims to evaluate the reporting quality of randomised controlled trials (RCTs) that evaluate AI technologies...

Full description

Bibliographic Details
Main Authors: Tina Felfeli, Niveditha Pattathil, Jonathan Z L Zhao, Olapeju Sam-Oyerinde
Format: Article
Language:English
Published: BMJ Publishing Group 2023-12-01
Series:BMJ Health & Care Informatics
Online Access:https://informatics.bmj.com/content/30/1/e100757.full
_version_ 1797364558761820160
author Tina Felfeli
Niveditha Pattathil
Jonathan Z L Zhao
Olapeju Sam-Oyerinde
author_facet Tina Felfeli
Niveditha Pattathil
Jonathan Z L Zhao
Olapeju Sam-Oyerinde
author_sort Tina Felfeli
collection DOAJ
description Purpose Many efforts have been made to explore the potential of deep learning and artificial intelligence (AI) in disciplines such as medicine, including ophthalmology. This systematic review aims to evaluate the reporting quality of randomised controlled trials (RCTs) that evaluate AI technologies applied to ophthalmology.Methods A comprehensive search of three relevant databases (EMBASE, Medline, Cochrane) from 1 January 2010 to 5 February 2022 was conducted. The reporting quality of these papers was scored using the Consolidated Standards of Reporting Trials-Artificial Intelligence (CONSORT-AI) checklist and further risk of bias was assessed using the RoB-2 tool.Results The initial search yielded 2973 citations from which 5 articles satisfied the inclusion/exclusion criteria. These articles featured AI technologies applied to diabetic retinopathy screening, ophthalmologic education, fungal keratitis detection and paediatric cataract diagnosis. None of the articles reported all items in the CONSORT-AI checklist. The overall mean CONSORT-AI score of the included RCTs was 53% (range 37%–78%). The individual scores of the articles were 37% (19/51), 39% (20), 49% (25), 61% (31) and 78% (40). All articles were scored as being moderate risk, or ‘some concerns present’, regarding potential risk of bias according to the RoB-2 tool.Conclusion A small number of RCTs have been published to date on the applications of AI in ophthalmology and vision science. Adherence to the 2020 CONSORT-AI reporting guidelines is suboptimal with notable reporting items often missed. Greater adherence will help facilitate reproducibility of AI research which can be a stimulus for more AI-based RCTs and clinical applications in ophthalmology.
first_indexed 2024-03-08T16:38:00Z
format Article
id doaj.art-2807364917c64ae9ae00ee4fe5e6ab8f
institution Directory Open Access Journal
issn 2632-1009
language English
last_indexed 2024-03-08T16:38:00Z
publishDate 2023-12-01
publisher BMJ Publishing Group
record_format Article
series BMJ Health & Care Informatics
spelling doaj.art-2807364917c64ae9ae00ee4fe5e6ab8f2024-01-05T12:10:09ZengBMJ Publishing GroupBMJ Health & Care Informatics2632-10092023-12-0130110.1136/bmjhci-2023-100757Adherence of randomised controlled trials using artificial intelligence in ophthalmology to CONSORT-AI guidelines: a systematic review and critical appraisalTina Felfeli0Niveditha Pattathil1Jonathan Z L Zhao2Olapeju Sam-Oyerinde3Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Ontario, CanadaQueen`s University School of Medicine, Faculty of Health Sciences, Kingston, Ontario, CanadaTemerty Faculty of Medicine, University of Toronto, Toronto, Ontario, CanadaDepartment of Ophthalmology, University College London, London, UKPurpose Many efforts have been made to explore the potential of deep learning and artificial intelligence (AI) in disciplines such as medicine, including ophthalmology. This systematic review aims to evaluate the reporting quality of randomised controlled trials (RCTs) that evaluate AI technologies applied to ophthalmology.Methods A comprehensive search of three relevant databases (EMBASE, Medline, Cochrane) from 1 January 2010 to 5 February 2022 was conducted. The reporting quality of these papers was scored using the Consolidated Standards of Reporting Trials-Artificial Intelligence (CONSORT-AI) checklist and further risk of bias was assessed using the RoB-2 tool.Results The initial search yielded 2973 citations from which 5 articles satisfied the inclusion/exclusion criteria. These articles featured AI technologies applied to diabetic retinopathy screening, ophthalmologic education, fungal keratitis detection and paediatric cataract diagnosis. None of the articles reported all items in the CONSORT-AI checklist. The overall mean CONSORT-AI score of the included RCTs was 53% (range 37%–78%). The individual scores of the articles were 37% (19/51), 39% (20), 49% (25), 61% (31) and 78% (40). All articles were scored as being moderate risk, or ‘some concerns present’, regarding potential risk of bias according to the RoB-2 tool.Conclusion A small number of RCTs have been published to date on the applications of AI in ophthalmology and vision science. Adherence to the 2020 CONSORT-AI reporting guidelines is suboptimal with notable reporting items often missed. Greater adherence will help facilitate reproducibility of AI research which can be a stimulus for more AI-based RCTs and clinical applications in ophthalmology.https://informatics.bmj.com/content/30/1/e100757.full
spellingShingle Tina Felfeli
Niveditha Pattathil
Jonathan Z L Zhao
Olapeju Sam-Oyerinde
Adherence of randomised controlled trials using artificial intelligence in ophthalmology to CONSORT-AI guidelines: a systematic review and critical appraisal
BMJ Health & Care Informatics
title Adherence of randomised controlled trials using artificial intelligence in ophthalmology to CONSORT-AI guidelines: a systematic review and critical appraisal
title_full Adherence of randomised controlled trials using artificial intelligence in ophthalmology to CONSORT-AI guidelines: a systematic review and critical appraisal
title_fullStr Adherence of randomised controlled trials using artificial intelligence in ophthalmology to CONSORT-AI guidelines: a systematic review and critical appraisal
title_full_unstemmed Adherence of randomised controlled trials using artificial intelligence in ophthalmology to CONSORT-AI guidelines: a systematic review and critical appraisal
title_short Adherence of randomised controlled trials using artificial intelligence in ophthalmology to CONSORT-AI guidelines: a systematic review and critical appraisal
title_sort adherence of randomised controlled trials using artificial intelligence in ophthalmology to consort ai guidelines a systematic review and critical appraisal
url https://informatics.bmj.com/content/30/1/e100757.full
work_keys_str_mv AT tinafelfeli adherenceofrandomisedcontrolledtrialsusingartificialintelligenceinophthalmologytoconsortaiguidelinesasystematicreviewandcriticalappraisal
AT nivedithapattathil adherenceofrandomisedcontrolledtrialsusingartificialintelligenceinophthalmologytoconsortaiguidelinesasystematicreviewandcriticalappraisal
AT jonathanzlzhao adherenceofrandomisedcontrolledtrialsusingartificialintelligenceinophthalmologytoconsortaiguidelinesasystematicreviewandcriticalappraisal
AT olapejusamoyerinde adherenceofrandomisedcontrolledtrialsusingartificialintelligenceinophthalmologytoconsortaiguidelinesasystematicreviewandcriticalappraisal